Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;39(10):3881-3889.
doi: 10.1007/s00345-020-03529-w. Epub 2021 Jan 3.

Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) Database

David-Dan Nguyen #  1 , Iman Sadri #  1 , Kyle Law  1 , Naeem Bhojani  2 , Dean S Elterman  3 , Ahmed S Zakaria  2 , Adel Arezki  1 , Franck Bruyère  4 , Luca Cindolo  5 , Giovanni Ferrari  5 , Carlos Vasquez-Lastra  6 , Tiago Borelli-Bovo  7 , Edgardo F Becher  8 , Hannes Cash  9 , Maximillian Reimann  9 , Enrique Rijo  10 , Vincent Misrai  11 , Kevin C Zorn  12
Affiliations

Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) Database

David-Dan Nguyen et al. World J Urol. 2021 Oct.

Abstract

Objectives: Previous analyses of the impact of median lobe presence on Greenlight photoselective vaporization of the prostate (PVP) outcomes were limited by their small sample size and the ability to adjust for important confounders. As such, we sought to investigate the impact of prostate median lobe presence on the operative outcomes of 180 W XPS GreenLight PVP using a large international database.

Methods: Data were obtained from the Global GreenLight Group (GGG) database which pools data of eight high-volume, experienced surgeons, from a total of seven international centers. All men with established benign prostatic hyperplasia who underwent GreenLight PVP using the XPS-180 W system between 2011 and 2019 were eligible for the study. Patients were assigned to two groups based on presence or absence of median lobes. Analyses were adjusted for patient age, prostate volume, body mass index, and American Society of Anesthesia (ASA) score.

Results: A total of 1650 men met the inclusion criteria. A median lobe was identified in 621 (37.6%) patients. Baseline prostate volume, patient age, and ASA score varied considerably between the two groups. In adjusted analyses, the operative and lasing time of patients with median lobes was 6.72 (95% CI 3.22-10.23; p < 0.01) minutes and 2.90 (95% CI 1.02-4.78; p < 0.01) minutes longer than the control group. Men with median lobes had similar postoperative functional outcomes to those without a median lobe except for a 1.59-point greater drop in the 12-month IPSS score compared to baseline (95% CI 0.11-3.08; p = 0.04) in the median lobe group, and a decrease in PVR after 6 months which was 46.51 ml (95% CI 4.65-88.36; p = 0.03) greater in patients with median lobes compared to men without median lobes.

Conclusions: Our findings suggest that the presence of a median lobe has no clinically significant impact on procedural or postoperative outcomes for patients undergoing Greenlight PVP using the XPS-180 W system.

Keywords: BPE; BPH; Greenlight PVP; Median lobe; Trilobed prostate.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPSgreenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial—The GOLIATH study. EurUrol 65:931–942. https://doi.org/10.1016/j.eururo.2013.10.040 - DOI
    1. Foster HE, Barry MJ, Dahm P et al (2019) Re: Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline. J Urol 203:1219. https://doi.org/10.1016/j.juro.2018.09.058 - DOI
    1. Brunken C, Seitz C, Woo HH (2015) A systematic review of experience of 180-W XPSGreenLight laser vaporisation of the prostate in 1640 men. BJU Int 116:531–537. https://doi.org/10.1111/bju.12955 - DOI - PubMed
    1. Ghobrial FK, Shoma A, Elshal AM et al (2020) A randomized trial comparing bipolar transurethral vaporization of the prostate with GreenLight laser (xps-180watt) photoselective vaporization of the prostate for treatment of small to moderate benign prostatic obstruction: outcomes after 2 years. BJU Int 125:144–152. https://doi.org/10.1111/bju.14926 - DOI - PubMed
    1. Hueber PA, Bienz MN, Valdivieso R et al (2015) Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 194:462–469. https://doi.org/10.1016/j.juro.2015.03.113 - DOI - PubMed

LinkOut - more resources